CSLLY

Johnson & Johnson Buys Momenta Pharmaceuticals

by

Image Source: Johnson & Johnson – Second Quarter of Fiscal 2020 IR Earnings Presentation By Callum Turcan On August 19, Johnson & Johnson (JNJ) announced it was acquiring Momenta Pharmaceuticals Inc (MNTA) for $52.50 per share in cash through a deal worth $6.5 billion (or $6.1 billion when including Momenta Pharmaceuticals’ net cash position). At the end of June 2020, Momenta Pharmaceuticals had ~$0.45 billion in cash and cash equivalents on hand with no debt on the books. We include shares of JNJ as a holding in both our Best Ideas Newsletter and Dividend Growth Newsletter portfolios. Overview This deal will give Johnson & Johnson’s Janssen pharmaceutical unit access to Momenta Pharmaceutical’s drug pipeline portfolio which focuses on therapeutics that … Read more

Dividend Increases/Decreases for the Week of September 13

by

Below we provide a list of firms that raised their dividends during the week ending September 13. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          Absa Group Limited (AGRPY): now $0.5992 per share dividend, was $0.5707. AFC Gamma (AFCG): now $0.33 per share quarterly dividend, was $0.15. Altria (MO): now $1.02 per share quarterly dividend, was $0.98. ANTA Sports Products Limited (ANPDY): now $3.712 per share semi-annual dividend, was $3.602. Bangkok Dusit Medical Services Public Company Limited (BDUUY): now $0.3199 per share semi-annual dividend, was $0.3095. Benchmark Electronics (BHE): … Read more